

<!DOCTYPE html>
<html lang="en-GB">
    <head>
        <meta charset="utf-8" /> 
        <meta content="IE=edge,chrome=1" name="X-UA-Compatible" />
        <meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport" />
        <!-- Timestamp: 03/10/2015 20:27:53 609487-WEB09-->
        <title>BNF | Pirfenidone</title>
        
        <script src="//cdn.optimizely.com/js/2225620398.js"></script> 
        <link href="//fonts.googleapis.com/css?family=Lato:200normal,200italic,300normal,300italic,400normal,400italic,700normal,700italic,900normal,900italic" rel="stylesheet" type="text/css" />
<link href="//cdn.nice.org.uk/v2/content/NICE.bootstrap.css" rel="stylesheet" type="text/css" />
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/styles/nice/NICE.base.less" rel="stylesheet" type="text/css" />
<link href="//cdn.nice.org.uk/v2/Content/FontAwesome.css" rel="stylesheet" type="text/css" />
<link href="//cdn.nice.org.uk/v2/Content/NICE.glyphs.css" rel="stylesheet" type="text/css" />
<!--[if IE 7]>
<link href="//cdn.nice.org.uk/v2/Content/NICE.glyphs-ie7.css" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if IE 7]>
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/Styles/nice/NICE.base.IE7.less" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if IE 8]>
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/Styles/nice/NICE.base.IE8.less" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if IE 9]>
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/Styles/nice/NICE.base.IE9.less" rel="stylesheet" type="text/css" />
<![endif]-->
<!--[if lt IE 9]>
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/Styles/nice/NICE.base.legacy-fonts.less" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="//www.nice.org.uk/Themes/NICE.Bootstrap/styles/nice/NICE.Print.css" media="print" rel="stylesheet" type="text/css" />
<!--[if lt IE 9]>
<script src="//cdn.nice.org.uk/v2/scripts/html5shiv/html5shiv.js" type="text/javascript"></script>
<![endif]-->
<script src="//ajax.aspnetcdn.com/ajax/jQuery/jquery-1.11.1.min.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/JSON/JSON2.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.GA.js" type="text/javascript"></script>

        <meta content="3963" name="cid" />


 
  <meta content="NICE" name="DC.Publisher" />
  <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" />
  <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" />
  <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" />
  <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" />
  <meta content="2014-08-05" name="DC.Issued" scheme="DCTERMS.W3CDTF" />
  <meta content="2014-08-05" name="DC.Modified" scheme="DCTERMS.W3CDTF" />
  <meta content="CorporatePage" name="DC.Type" scheme="NICE.Publication.Types" />
  
        
        <meta content="Local government | NICE communities | About | NICE" name="DC.Title" />
        <meta content="#f6f6f6" name="msapplication-TileColor" />
        <meta content="//cdn.nice.org.uk/V3/Content/nice/favicon-144.png" name="msapplication-TileImage" />
        <link rel="shortcut icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon.ico" />
        <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
            <link rel="canonical" href="https://www.nice.org.uk/about/nice-communities/local-government" />
        <!--[if IE 6]><script>var ieVersion = 6;</script><![endif]-->
        <!--[if IE 7]><script>var ieVersion = 7;</script><![endif]-->
        <!--[if IE 8]><script>var ieVersion = 8;</script><![endif]-->
        <!-- addthis config -->
        <script>
            var addthis_config = {
                data_ga_property: 'UA-28620212-1',
                data_ga_social: true,
                ui_show_promo: false,
                services_compact: '',
                pubid: 'ra-5506be4a13ce4bf0'
            };
            $(function () {
                addthis.init();
            });
        </script>
        
<script>
jQuery.fn.topLink = function(settings) {
  settings = jQuery.extend({
    min: 1,
    fadeSpeed: 100
  }, settings);
  return this.each(function() {
    //listen for scroll
    var el = jQuery(this);
    el.hide(); //in case the user forgot
    jQuery(window).scroll(function() {
      if(jQuery(window).scrollTop() >= settings.min)
      {
        el.fadeIn(settings.fadeSpeed);
      }
      else
      {
        el.fadeOut(settings.fadeSpeed);
      }
    });
  });
};

//usage w/ smoothscroll
jQuery(document).ready(function() {
  //set the link
  jQuery('#top-link').topLink({
    min: 500,
    fadeSpeed: 100
  });
  //smoothscroll
  jQuery('#top-link').click(function(r) {    
    jQuery("html, body").animate({ scrollTop: 0 }, 300);
  });
});
</script>
        
<style>

#two-columns {
 
 width: 100%;
 -moz-column-count: 2;
  -moz-column-gap: 64px;
  -webkit-column-count: 2;
  -webkit-column-gap: 64px;
  column-count: 2;
  column-gap: 64px;
 }
 

 h1, h2, h3, h4, h5, h6 {
    margin: 12px 0;
    font-family: inherit;
    font-weight: 400;
    line-height: 24px;
    color: #4a4a4a;
    text-rendering: optimizelegibility;
}
hr {
    
    border: 0margin: 24px 0;;
    border-top: 1px solid #81939E;
    border-bottom: 1px solid #fff;
}
li {
    line-height: 32px;
    font-size: 18px;
}
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }
  .tab-pane {
    padding: 0px;
}
  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype=reg]::before {
    content: "\00ae";
  }
  tm[tmtype=copy]::before {
    content: "\00a9";
  }
  tm[tmtype=trade]::before {
    content: "\2122";
  }
#wrap {height:auto; width:auto; margin:0 auto;}
#top-link  {display:none; position:fixed; left:50%; margin-left:78px; bottom:320px; color:#292f33; font-weight:400; text-decoration:none; border:none; background:#c1ccd2; padding:5px 12px; box-shadow: inset 0 -1px 0 0 rgba(0,0,0,.1); opacity:0.8 }

</style>
        <!-- end addthis config -->
        
    </head>


<body data-spy="scroll" data-target=".aside-primary" >
                
<div id='gtmscript'></div>    <!-- Google Tag Manager -->
            <noscript>
                <iframe src="//www.googletagmanager.com/ns.html?id=GTM-M55QTQ"
                        height="0" width="0" style="display:none;visibility:hidden"></iframe>
            </noscript>
            <script>
                (function (w, d, s, l, i) {
                    w[l] = w[l] || []; w[l].push({
                        'gtm.start':
                            new Date().getTime(), event: 'gtm.js'
                    }); var f = d.getElementsByTagName(s)[0],
                            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
                                '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
                })(window, document, 'script', 'dataLayer', 'GTM-M55QTQ');</script>
            <!-- End Google Tag Manager -->
        
        
<div id="printpane"></div>
    <div class="nice-tophat">
        <div class="nice-global" id="nice-global">
            <div class="tophat-inner">
                <div class="zone zone-navigation">

<div class="widget-navigation widget-search-widget widget">
    <div class="widget-content">
      
    </div>
  </div>

<div class="widget-navigation widget-menu-widget widget">
    <div class="widget-content">
      <ul class="nav nav-pills menu">
    
    

<li><a href="/news">News</a>
</li>

<li><a href="/about">About</a>
</li>

<li><a href="/get-involved">Get involved</a>
</li>

<li><a href="/about/nice-communities">Communities</a>
</li>
</ul>
    </div>
  </div></div>
            </div>
        </div>
    </div>

<div class="layout ">
    <div class="">
            <div class="zone zone-content">



<div class="page-content corporate-content">
  <div class="metadata">
    
  </div>
  
<div class="row">
<ul class="breadcrumb"> 
<li><a href="#">Home</a><i class="divider icon-nice-chevron-right"></i></li>
<li><a href="#">Drugs</a> <i class="divider icon-nice-chevron-right"></i></li>
<li class="active"><a href="#">Pirfenidone</a></li>
</ul>
</div>

    <div class="row">
<div class="span8">
<h1 style="font-size: 48px">PIRFENIDONE</h1>
<div class="row">
<div style="height:1em">&nbsp;</div>
<ol id="two-columns">
         <li><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#drugAction" data-toggle="tab">Drug action</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#renalImpairment" data-toggle="tab">Renal impairment</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#nationalFunding" data-toggle="tab">National funding/access decisions</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
</ol>

<hr>

<div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Treatment of mild to moderate idiopathic pulmonary fibrosis (initiated under specialist supervision)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses unstyled">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 267 mg 3 times a day for 7 days, then increased to 534 mg 3 times a day for 7 days, then increased to 801 mg 3 times a day.</li>
            </ul>
          </section>
        </section>
        
            <section class="doseAdjustments">
                <h3>Dose adjustments due to interactions</h3>
              <p>Caution with concomitant use with ciprofloxacin&#8212;reduce dose of pirfenidone to 534&#8239;mg three times daily with high-dose ciprofloxacin (750&#8239;mg twice daily).</p> <p>Caution with concomitant use of drugs known to cause photosensitivity&#8212;if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>
            </section>
        
        
        
        
      </section>


      <section class="tab-pane" id="drugAction">
        <h2>Drug action</h2>

            <section class="drugAction">
              <p>The exact mechanism of action of pirfenidone is not yet understood, but it is believed to slow down the progression of idiopathic pulmonary fibrosis by exerting both antifibrotic and anti-inflammatory properties.</p>
            </section>
      </section>

      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <p>Manufacturer advises avoid&#8212;no information available.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="generalInformation">
              <p>Use with caution in mild to moderate hepatic impairment, particularly if concomitant use of CYP1A2 inhibitors.</p><p>Avoid use in severe hepatic impairment.</p>
            </section>
      </section>

      <section class="tab-pane" id="renalImpairment">
        <h2>Advice regarding renal impairment</h2>

        
            <section class="generalInformation">
              <p>Avoid use if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>
            </section>
      </section>

      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

          <ul class="unstyled">
            <li>Cigarette smoking</li>
          </ul>
      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Side effects</h2>

          <h3>Common or very common:</h3>
          <hr style="margin: 10px 0;">
              <p>
                Abdominal discomfort, anorexia, arthralgia, constipation, diarrhoea, dizziness, dry skin, dysgeusia, dyspepsia, erythema, flatulence, gastritis, gastro-oesophageal reflux disease, headache, hot flush, insomnia, malaise, myalgia, nausea, non-cardiac chest pain, photosensitivity reaction, pruritus, raised hepatic enzymes, rash, somnolence, upper respiratory tract infection, urinary tract infection, vomiting, weight loss,
              </p>
              <h3>Rare</h3>
              <hr style="margin: 10px 0;">
              <p>
                 Raised bilirubin in combination with raised hepatic transaminases,
              </p>
        
        
            <section class="advice">
            <h3>Side-effects, further information</h3>
            <hr style="margin: 10px 0;">
              <p>Gastrointestinal side-effects may require dose reduction or treatment interruption&#8212;consult product literature.</p>
            </section>
        
      </section>


      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Patients and carer advice</h2>
        <h3>Driving and skilled tasks</h3>
 <hr style="margin: 10px 0;">
<p>Dizziness or malaise may affect performance of skilled tasks (e.g. driving).</p>

      </section>

      <section class="tab-pane" id="nationalFunding">
        <h2>National funding/access decisions</h2>

            <section class="niceTechnologyAppraisals">
              <h3 class="fundingIdentifier">NICE</h3>
              <p outputclass="title">Pirfenidone for treating idiopathic pulmonary fibrosis (April 2013)</p> <p>Pirfenidone is recommended as an option for treating idiopathic pulmonary fibrosis only if:</p> <ul> <li>the patient has a forced vital capacity (FVC) between 50% and 80% predicted, <b>and</b> </li> <li>the manufacturer provides pirfenidone with the discount agreed in the patient access scheme.<p>Treatment should be discontinued if there is evidence of disease progression, defined as a decline in predicted FVC of 10% or more within any 12 month period.</p> <p>Patients currently receiving pirfenidone that is not recommended according to the above criteria should have the option to continue treatment until they and their clinician consider it appropriate to stop.</p> </li> </ul><xref format="html" href="http://www.nice.org.uk/TA282">www.nice.org.uk/TA282</xref>
                <a href="http://www.nice.org.uk/TA282" target="_blank">www.nice.org.uk/TA282</a>
            </section>
      </section>


      <section class="tab-pane" id="cautions">
        <h2>Cautions</h2>
        
        <h3>Cautions, further information</h3>
          <hr style="margin: 10px 0;">
<p><strong>Photosensitivity</strong><br>
Avoid exposure to direct sunlight—if photosensitivity reaction or rash occurs, dose adjustment or treatment interruption may be required (consult product literature).</p>
<p><strong>Treatment interruption</strong><br>
If treatment is interrupted for 14 consecutive days or more, the initial 2 week titration regimen should be repeated; if treatment is interrupted for less than 14 consecutive days, the dose can be resumed at the previous daily dose without titration.</p>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        <hr style="margin: 10px 0;">
            <section class="patientParameters">
              <p>Monitor for weight loss.</p><p>Test liver function before treatment, then at monthly intervals for the next 6 months, and then every 3 months thereafter; review if abnormal liver function tests&#8212;dose reduction, treatment interruption or discontinuation may be required (consult product literature).</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
<h2>Medicinal forms</h2>

<section class="licensingVariationStatement">
<p>There can be variation in the licensing of different medicines containing the same drug.<bR>
<strong>Capsule</strong></p>
<hr style="margin: 10px 0;">
<p><strong>Cautionary and advisory labels</strong><br>
Label 21 - Take with or just after food, or a meal<br>
Label 25 - Swallow this medicine whole. Do not chew or crush</p>
<p>Esbriet 267mg capsules (Roche Products Ltd) ▼</p>
</section>

 



<table class="table table-bordered">
            <thead>
              <tr>
                <th class="strengthOfActiveIngredient">Strength</th>
                <th class="packSize">Pack size</th>
                <th class="legalCategory">Legal category</th>
                <th class="nhsIndicativeInfo">NHS indicative price</th>
                <th class="drugTariffInfo" title="Drug Tariff (Part VIII Category M)">Drug Tariff</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td class="strength">Pirfenidone 267 mg</td>
                <td class="packSize">63 <span class="unitOfMeasure">capsule</span></td>
                <td class="legalCategory">POM</td>
                <td class="nhsIndicativeInfo">£501.92</td>
                <td class="drugTariffInfo">—</td>
              </tr>
              <tr>
                <td class="strength">Pirfenidone 267 mg</td>
                <td class="packSize">252 <span class="unitOfMeasure">capsule</span></td>
                <td class="legalCategory">POM</td>
                <td class="nhsIndicativeInfo">£2007.70</td>
                <td class="drugTariffInfo">—</td>
              </tr>
              <tr>
                <td class="strength">Pirfenidone 267 mg</td>
                <td class="packSize">270 <span class="unitOfMeasure">capsule</span></td>
                <td class="legalCategory">POM</td>
                <td class="nhsIndicativeInfo">£2151.10</td>
                <td class="drugTariffInfo">—</td>
              </tr>
            </tbody>
          </table>

<h2>All products</h2>

<table class="table table-bordered">
          <thead>
            <tr>
              <th class="strength">Strength</th>
              <th class="packSize">Size</th>
              <th class="packSize">Unit</th>
              <th class="product">Product</th>
              <th class="manufacturer">Manufacturer</th>
              <th class="legalCategory">Legal category</th>
              <th class="nhsIndicativeInfo">NHS indicative price</th>
              <th class="drugTariffInfo" title="Drug Tariff (Part VIII Category M)">Drug Tariff</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td class="strengthOfActiveIngredient">Pirfenidone 267 mg</td>
              <td class="packSize">63</td>
              <td class="unitOfMeasure">capsule</td>
              <td class="product">Esbriet 267mg capsules</td>
              <td class="manufacturer">(Roche Products Ltd)</td>
              <td class="legalCategory">POM</td>
              <td class="nhsIndicativeInfo">£501.92</td>
              <td class="drugTariffInfo">—</td>
            </tr>
            <tr>
              <td class="strengthOfActiveIngredient">Pirfenidone 267 mg</td>
              <td class="packSize">252</td>
              <td class="unitOfMeasure">capsule</td>
              <td class="product">Esbriet 267mg capsules</td>
              <td class="manufacturer">(Roche Products Ltd)</td>
              <td class="legalCategory">POM</td>
              <td class="nhsIndicativeInfo">£2007.70</td>
              <td class="drugTariffInfo">—</td>
            </tr>
            <tr>
              <td class="strengthOfActiveIngredient">Pirfenidone 267 mg</td>
              <td class="packSize">270</td>
              <td class="unitOfMeasure">capsule</td>
              <td class="product">Esbriet 267mg capsules</td>
              <td class="manufacturer">(Roche Products Ltd)</td>
              <td class="legalCategory">POM</td>
              <td class="nhsIndicativeInfo">£2151.10</td>
              <td class="drugTariffInfo">—</td>
            </tr>
          </tbody>
        </table>

</section>
    </div>
</div>
<div id="wrap">

 <a href="#top" id="top-link">Back to Top</a>
           

</div>
</div>

<div class="span4">
<h2 style="font-size: 36px">Sub-sections</h2>
<ul class="unstyled">
<li><a href="#">Drug interactions: Pirfenidone</a></li>
<li><a href="#">TBC</a></li>
<li><a href="#">TBC</a></li>
</ul>
<h2 style="font-size: 36px">Related links</h2>
<ul class="unstyled">
<li><a href="#">TBC</a></li>
<li><a href="#">TBC</a></li>
<li><a href="#">TBC</a></li>
</ul>

</div>
</div>


      
</div></div>        </div>
</div> <!-- layout -->

<div class="callouts">
    <div class="container">
        <a href="/get-involved" class="callout-involved track-link" data-track="getinvolvedtab" data-track-category="get involved tab" data-track-action="clicked" data-track-label="http://www.nice.org.uk/about/nice-communities/local-government">Get involved</a>
    </div>
</div>

<footer class="footer-wrapper">
    <div class="footer">
        <div class="navbar navbar-inverse">
            <div class="navbar-inner">
                <div class="container">
                    <div class="zone zone-footer">

<div class="widget-footer widget-menu-widget widget">
    <div class="widget-content">
      <ul class="nav nav-pills menu">
    
    

<li><a href="/news">News</a>
</li>

<li><a href="/about">About</a>
</li>

<li><a href="/get-involved">Get involved</a>
</li>

<li><a href="/about/nice-communities">Communities</a>
</li>
</ul>
    </div>
  </div>

<div class="widget-footer widget-html-widget widget">
    <div class="widget-content">
      <ul class="nav nav-pills">
<li><a href="/leave-feedback"><span>Leave Feedback</span></a></li>
</ul>
    </div>
  </div></div>
                </div>
            </div>
        </div>
        <div class="container">
            <a href="http://www.nice.org.uk" class="footer-logo"><i class="logo icon-nice-logo"></i></a>

            <ul class="nav nav-services">
                <li><a href="http://pathways.nice.org.uk"><i class="icon-nice-pathways"></i> NICE Pathways</a></li>
                <li><a href="http://www.nice.org.uk/guidance"><i class="icon-nice-guidance"></i> Guidance</a></li>
                <li><a href="http://www.nice.org.uk/standards-and-indicators"><i class="icon-nice-standards"></i> Standards &amp;&nbsp;Indicators</a></li>
                <li><a href="http://www.evidence.nhs.uk"><i class="icon-nice-evidence"></i> Evidence services</a></li>
            </ul>

            <div class="legal-panel">
                <div class="social-panel">
                    <!-- AddThis Button BEGIN -->
                    <p class="social-follow addthis_toolbox">
                        Follow Us
                        <a class="addthis_button_twitter_follow" addthis:userid="nicecomms" target="_blank" title="Follow on Twitter" href="#">
                            <i class="icon-twitter"></i>
                        </a>
                    </p>
                    <!-- AddThis Button END -->
                </div>

                <ul class="nav nav-legal">
                    <li><a href="//www.nice.org.uk/about">About</a></li>
                    <li><a href="//www.nice.org.uk/accessibility">Accessibility</a></li>
                    <li><a href="//www.nice.org.uk/freedom-of-information">Freedom of information</a></li>
                    <li><a href="//www.nice.org.uk/get-involved/contact-us">Contact Us</a></li>
                    <li><a href="//www.nice.org.uk/glossary">Glossary</a></li>
                    <li><a href="//www.nice.org.uk/terms-and-conditions">Terms and conditions</a></li>
                    <li><a href="/news/nice-newsletters-and-alerts">Subscribe</a></li>
                    <li><a href="/help">Help</a></li>
                </ul>

                <p class="legal-copyright">Copyright &copy; 2014 National Institute for Health and Care Excellence. All rights reserved.</p>
            </div>
        </div>
    </div>
</footer>

        <script src="//cdn.nice.org.uk/V3/scripts/nice/NICE.eprivacy-policy.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/v2/scripts/twitter.bootstrap.min.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/v2/scripts/NICE.bootstrap.min.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/tabdrop/bootstrap-tabdrop.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/nice/NICE.TabDrop.js" type="text/javascript"></script>
<script src="//cdn.nice.org.uk/V3/Scripts/nice/NICE.EventTracking.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.GATracking.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.LinkFixes.js" type="text/javascript"></script>
<script src="//www.nice.org.uk/Themes/NICE.Bootstrap/scripts/niceorg/NICE.Additions3.js" type="text/javascript"></script>
<script src="//s7.addthis.com/js/300/addthis_widget.js#async=1" type="text/javascript"></script>


        

    <script src="//cdn.nice.org.uk/V3/Scripts/nice/NICE.TopHat.dev.js"
            data-environment="Live"
            data-search="/search?q=%term"
            data-typeaheadtype="remote"
            data-typeaheadsource="/autocomplete?%query"
                        async></script>



    
        
        <script type="text/javascript">
            $(document).ajaxSend(function (event, jqxhr, settings) {
                if (settings.url.indexOf("?") >= 0) {
                    settings.url = settings.url + "&ajax=ajax";
                } else {
                    settings.url = settings.url + "?ajax=ajax";
                }
            })
        </script>
        <script type="text/javascript">
            var is_touch_device = 'ontouchstart' in document.documentElement;
            if (is_touch_device) {
                $('body').addClass('touch-screen-device');
            } else {
                $('body').addClass('non-touch-screen-device');
            }
        </script>
    </body>
</html>

